(Q36820892)

16 August 2017

1 reference

title

Clinical update: irritable bowel syndrome (English)

1 reference

16 August 2017

1

Robin Spiller

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

369

1 reference

16 August 2017

issue

9573

1 reference

16 August 2017

page(s)

1586-1588

1 reference

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Searching for the Answer to Irritable Bowel Syndrome in the Colonic Mucosa: SERTainty and UnSERTainty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Irritable bowel syndrome symptom patterns: frequency, duration, and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

The economic consequences of irritable bowel syndrome: a US employer perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Irritable Bowel Syndrome–Prognosis and Diagnostic Safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Food intolerance and the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Long term benefits of hypnotherapy for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Tegaserod for the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960726-0

7 January 2021

10.1016/S0140-6736(07)60726-0

Identifiers

DOI

1 reference

16 August 2017

1 reference